$11.67
-0.17 (-1.44%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+196.6% upside
Low Target
$23.82
Average Target
$34.61
High Target
$34.97
Current Price
$11.67
Current
$11.67
$11.67
Target
$34.61
$34.61
$23.82
$34.61 avg
$34.97
Scenario Analysis
Bear Case
$23.82
104.1%
Low target
Base Case
$34.61
+196.6%
Avg target
Bull Case
$34.97
+199.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$11.81
-1.2% from high
52-Week Low
$3.22
+262.4% from low
Target vs 52W High
$34.61
+193.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |